Delivery Order SPE2DB25D3504-SPE2DB25FVUNC

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,555.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside procurement. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,001.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a period of performance through April 2025. The contract is a firm-fixed price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,527.83, is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug...
This federal contract award, valued at $5,190.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award, valued at $1,996.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,300.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,157.06 firm-fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used for diabetes management. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,718.39 firm fixed price contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. The contract has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $1,094.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, and has a completion date of February 14, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,441.81 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUNC
    Delivery Order

This federal contract award, valued at $2,869.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a performance period through May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/31/25, 10:10 AM